Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

Samjin Pharmaceuticals Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cash & Equivalents	2,341	7,941	2,491	2,338	1,191
Short-Term Investments	2,321	3,770	7,427	2,780	5,789
Cash & Short-Term Investments	4,663	11,711	9,918	5,118	6,980
Cash Growth	-60.18%	18.08%	93.77%	-26.67%	33.05%
Accounts Receivable	59,780	56,671	96,970	116,212	107,031
Other Receivables	103.58	1,013	-	-	539.58
Receivables	59,883	57,684	96,970	116,212	107,571
Inventory	68,595	69,709	26,061	24,148	25,123
Prepaid Expenses	151.69	96.94	-	-	15.61
Other Current Assets	975.88	670.68	387.75	147.23	231.85
Total Current Assets	134,268	139,872	133,336	145,626	140,433
Property, Plant & Equipment	198,068	168,901	61,382	52,734	44,593
Long-Term Investments	61,114	7,058	6,533	6,200	2,846
Other Intangible Assets	10,340	10,313	2,223	2,332	2,275
Long-Term Accounts Receivable	-0	0	711.45	1,212	-
Long-Term Deferred Tax Assets	-	2,166	-	-	-
Other Long-Term Assets	2,767	4,187	-	-	1,078
Total Assets	406,557	332,496	204,186	208,104	191,225

Liabilities

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Accounts Payable	13,180	12,236	23,799	20,208	4,729
Accrued Expenses	4,109	4,990	-	-	1,151
Short-Term Debt	36,000	10,000	43,000	41,440	30,000
Current Portion of Long-Term Debt	8,333	4,167	-	-	8,000
Current Portion of Leases	508.43	350.86	-	-	-
Current Income Taxes Payable	4,782	5,180	-	-	4,523
Current Unearned Revenue	71.26	-	-	-	-
Other Current Liabilities	14,668	12,590	3,929	8,066	5,706
Total Current Liabilities	81,652	49,514	70,728	69,714	54,109
Long-Term Debt	42,500	39,833	-	-	3,000
Long-Term Leases	170.74	154.51	-	-	-
Pension & Post-Retirement Benefits	-	3,298	13,816	12,584	9,269
Long-Term Deferred Tax Liabilities	1,145	-	1,982	1,095	133.23
Other Long-Term Liabilities	5,225	5,528	4,920	4,831	5,063
Total Liabilities	130,693	98,328	91,446	88,224	71,574

Shareholders' Equity

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Common Stock	13,900	13,900	13,900	13,900	13,500
Additional Paid-In Capital	38,742	25,580	23,884	23,877	23,877
Retained Earnings	227,895	207,750	93,938	89,282	74,341
Treasury Stock	-13,762	-21,631	-	-	-4,950
Comprehensive Income & Other	8,569	8,569	-18,982	-7,179	12,882
Total Common Equity	275,344	234,168	112,739	119,880	119,651
Minority Interest	520.12	-	-	-	-
Shareholders' Equity	275,864	234,168	112,739	119,880	119,651
Total Liabilities & Equity	406,557	332,496	204,186	208,104	191,225

Additional Metrics

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Total Debt	87,512	54,505	43,000	41,440	41,000
Net Cash (Debt)	-82,850	-42,795	-33,082	-36,322	-34,020
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-6538.33	-3478.44	-2540.61	-2787.46	-2573.83
Filing Date Shares Outstanding	13.23	12.3	13.03	13.04	13.22
Total Common Shares Outstanding	13.23	12.3	13.03	13.04	13.22
Working Capital	52,616	90,358	62,608	75,912	86,325
Book Value Per Share	20810.66	19033.68	8650.37	9190.86	9053.10
Tangible Book Value	265,004	223,855	110,516	117,548	117,376
Tangible Book Value Per Share	20029.18	18195.46	8479.80	9012.07	8881.00
Land	21,700	20,968	-	-	15,262
Buildings	147,899	109,014	-	-	26,946
Machinery	94,509	74,908	-	-	23,721
Construction In Progress	20,688	41,821	-	-	2,389

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2013

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error